Mucin phenotypic expression in early signet ring cell carcinoma of the stomach: Its relationship with the clinicopathologic factors

Digestive Diseases and Sciences

Volumn 49, Issue 3, 2004, Pages 417-424

  Aihara, Ryuusuke ^a   Mochiki, Erito ^a   Kamiyama, Yoichi ^a   Kamimura, Hitoshi ^a   Asao, Takayuki ^a   Kuwano, Hiroyuki ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Early gastric carcinoma; Intestinal metaplasia; M1: MUC2; MUC6; Signet ring cell carcinoma

Indexed keywords

MUCIN; MUCIN 1; MUCIN 2; MUCIN 6;

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER SURGERY; CLINICAL FEATURE; EARLY CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MINIMALLY INVASIVE SURGERY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; SIGNET RING CARCINOMA; SIGNET RING CARCINOMA GASTRIC TYPE; SIGNET RING CARCINOMA GASTROINTESTINAL TYPE; SIGNET RING CARCINOMA INTESTINAL TYPE; SIGNET RING CARCINOMA UNCLASSIFIED TYPE; STOMACH CARCINOMA; SUBMUCOSA INVASION; TUMOR VOLUME;

AGED; CARCINOMA, SIGNET RING CELL; FEMALE; GASTRIC MUCIN; GASTRIC MUCOSA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PHENOTYPE; STOMACH NEOPLASMS;

EID: 1842504143     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000020496.98711.14     Document Type: Article

References (27)

1. Nishi M, Omori Y, Miwa K: Japanese Classificalion of Gastric Carcinoma, 1st English ed. Tokyo, Kanehara, 1995, pp 6-15
2. Ida K, Matsumoto N, Kojima T, Katou R, Okuda J: Endoscopic therapy for early gastric cancer. Gastroenterology 24:512-517, 1997
3. Hamada T, Kondou K, Itagaki Y, Kitamura S, Yatsumaki G, Nakatani H: Indication for endoscopie resection for undifferentiated type of minute gastric carcinomas from the aspect of their size. Stomach Intestine (Tokyo) 30:1279-1287, 1995
4. Hyung WJ, Noh SH, Lee JH: Early gastric carcinoma with signet ring cell histology. Cancer 94:78-83, 2002
5. Olsuji E, Yamaguchi T, Sawai K: Characterization of signet ring cell carcinoma of the stomach. J Surg Oncol 67:216-220, 1998
6. Silva E, Teixeira A, David L, Cameiro F, Reis CA, Sobrinho-Simoes J, Serpa J, Veerman E, Bolscher J, Sobrinho-Simoes M: Mucins as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch 440:311-317, 2002
7. Kim YS, Gum JR jr: Diversity of mucin genes, structure, function, and expression. Gastroenterology 109:999-1023, 1995
8. Bara J, Gautier R, Daher N, Zaghouani H, Decaens C: Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucoase. Cancer Res 46:3983-3989, 1986
9. Bara J, Gautier R, Mouradian P, Decaens C, Daher N: Oncofetal mucin M1 epitope family: Characterization and expression during colonic carcinogenesis. Int J Cancer 47:304-310, 1991
10. Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M: Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59:1003-1007, 1999
11. Tajima Y, Shimoda T, Nakanishi Y: Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: Immunohistochemical analysis of 136 lesions. Oncology 61:212-220, 2001
12. Ajioka Y, Watanabe H, Jass JR: MUC1 and MUC2 mucin in flat and polypoid colorectal adenomas. J Clin Pathol 50:417-421, 1997
13. Tytgat KM, Buller HA, Opdam FJ, Kim YS, Einerhand AW, Dekker J: Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. Gastroenterology 107:1352-1363, 1994
14. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G: Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 51:165-171, 2001
15. Yoshikawa A, Inada Ki K, Yamaehika T, Shimizu N, Kaminishi M, Tatematsu M: Phenotypie shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression. Gastric Cancer 1:134-141, 1998
16. Bamba M, Sugihara H, Kushima R, Okada K, Tsukashila S, Horinouchi M, Hattori T: Time-dependeni expression of intestinal phenotype in signel ring cell carcinoma of the human stomach. Virchows Arch 438:49-56, 2001
17. Yamachika T, Inada K, Fujimitsu Y, Nakamura S, Yamamura Y, Kitou T, Itzkowitz SH, Werther JL, Miki K, Tatematsu M: Intestinalization of gastric signet ring cell carcinomas with progression. Virchows Arch 431:103-110, 1997
18. Watanabe H, Jass JR, Sobin LH: Histological typing of oesophageal and gastric tumours. In WHO International Histological Classification of Tumors. 2nd ed. Berlin, Springer-Verlag, 1990
19. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal type carcinoma. Acta Pathol Microbiol Scand 64:31-49, 1965
20. Nakamura K, Sugano H, Takagi K: Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 59:251-258, 1968
21. Makuuchi H, Kise Y, Shimada H, Chino O, Tanaka H: Endoscopic mucosal resection for early gastric cancer. Semin Surg Oncol 17:108-116, 1999
22. Shiraishi N, Adachi Y, Kitano S, Bandoh T, Katsuta T, Morimoto A: Indication for and outcome of laparoscopy-assisted Billroth I gastrectomy. Br J Surg 86:541-544, 1999
23. Filipe MI, Potet F, Bogomoletz WV, Dawson PA, Fabiani B, Chauveinc P, Fenzy A, Gazzard B, Goldfain D, Zeegen R: Incomplete sulphomucin secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centers. Gut 26:1319-1326, 1985
24. Jass JR: Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol 33:801-810, 1980
25. Kirchner T, Muller S, Hattori T, Mukaisyo K, Papadopoulos T, Brabletz T, Jung A: Metaplasia, intraepithelial neoplasia and early cancer of the stomach are related to dedifferentiated epithelial cells defined by cytokeratin-7 expression in gastritis. Virchows Arch 439(4):512-522, 2001
26. Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumor progression. Nature 355:846-847, 1992
27. Yokota J, Sugimura T: Multiple steps in carcinogenesis involving alterations of multiple tumor suppresser genes. FASEB J 7:920-925, 1993